TOKYO – Japan, with the world's third-highest rate of stomach cancer behind Mongolia and the Republic of Korea, will soon have another combination drug mix to help treat the disease.

TOKYO – Japan, with the world's third-highest rate of stomach cancer behind Mongolia and the Republic of Korea, will soon have another combination drug mix to help treat the disease.

TOKYO – Japanese authorities are stepping up their push to become more transparent by working with foreign companies in the health care product market.

TOKYO – Japanese authorities are stepping up their push to become more transparent by working with foreign companies in the health care product market.

TOKYO – With the introduction of new legislation that makes approvals easier, Japan aims to be the global leader in regenerative medicine.

TOKYO – Japan's declining sales of long-listed drugs will force some pharmaceutical companies to shift their business models. Sales of most of these drugs fell short of forecasts between April and September, and led drug companies to cut their full-year forecasts for sales by more than 70 percent.

TOKYO – Japan's declining sales of long-listed drugs will force some pharmaceutical companies to shift their business models. Sales of most of these drugs fell short of forecasts between April and September, and led drug companies to cut their full-year forecasts for sales by more than 70 percent.